Utilization and Outcomes of Primary Prevention Implantable Cardioverter‐Defibrillators in Patients With Hypertrophic Cardiomyopathy

Background There is uncertainty about the appropriate use of primary prevention implantable cardioverter‐defibrillators (ICDs) among older patients with hypertrophic cardiomyopathy. Methods and Results Patients with hypertrophic cardiomyopathy who received a primary prevention ICD between 2010 and 2...

Descripció completa

Dades bibliogràfiques

Autors principals:	Sarah A. Goldstein, Kevin F. Kennedy, Daniel J. Friedman, Sana M. Al‐Khatib, Andrew Wang
Format:	Artigo
Idioma:	Inglês
Publicat:	Wiley 2023-08-01
Col·lecció:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Matèries:	hypertrophic cardiomyopathy implantable cardioverter‐defibrillator mortality risk stratification sudden cardiac death
Accés en línia:	https://www.ahajournals.org/doi/10.1161/JAHA.122.029293
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!